tiprankstipranks
Advertisement
Advertisement
BioNTech price target raised to $130 from $128 at BofA
PremiumThe FlyBioNTech price target raised to $130 from $128 at BofA
20d ago
BioNTech announce Phase 2 cohort of BNT323 met primary efficacy endpoint
Premium
The Fly
BioNTech announce Phase 2 cohort of BNT323 met primary efficacy endpoint
20d ago
BioNTech price target raised to $126 from $125 at Morgan Stanley
Premium
The Fly
BioNTech price target raised to $126 from $125 at Morgan Stanley
23d ago
BioNTech Showcases Late-Stage Lung Cancer Portfolio at ELCC 2026 With Promising Clinical Data
PremiumCompany AnnouncementsBioNTech Showcases Late-Stage Lung Cancer Portfolio at ELCC 2026 With Promising Clinical Data
1M ago
District court rules federal limits to vaccines not based on science, NYT says
Premium
The Fly
District court rules federal limits to vaccines not based on science, NYT says
2M ago
BioNTech price target lowered to $94 from $116 at TD Cowen
Premium
The Fly
BioNTech price target lowered to $94 from $116 at TD Cowen
2M ago
BioNTech: Attractive Near-Cash Valuation with Robust Late-Stage Pipeline Offsetting Revenue Declines and Leadership Transition Risks
PremiumRatingsBioNTech: Attractive Near-Cash Valuation with Robust Late-Stage Pipeline Offsetting Revenue Declines and Leadership Transition Risks
2M ago
Jefferies cuts BioNTech price target, says stock is cheap
Premium
The Fly
Jefferies cuts BioNTech price target, says stock is cheap
2M ago
Clear Street lowers BioNTech price target, says buy on weakness
Premium
The Fly
Clear Street lowers BioNTech price target, says buy on weakness
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100